Stockreport

Catalyst Pharmaceuticals announces $200M share repurchase program through 2026 [Seeking Alpha]

Catalyst Pharmaceuticals, Inc.  (CPRX) 
Last catalyst pharmaceuticals, inc. earnings: 3/16 05:26 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.catalystpharma.com
PDF The program allows for the repurchase of outstanding common stock between October 1, 2025, and December 31, 2026. Source: Press release More on Catalyst Pharmaceuti [Read more]